← All sarcoma trials
Recruiting nowAll ages

ICONIC: Improving Outcomes Through Collaboration in OsteosarComa

Sponsor: University College, London · NCT04132895 on ClinicalTrials.gov ↗

Conditions studied

Osteosarcoma

What it tests

  • observational only, no interventions are prescribed in protocol.other

Where it's running22 sites

22 international sites
  • University College Hospitals London NHS Foundation Trust

    London, Greater London, United Kingdom NW1 2BU

    Recruiting now
  • NHS Grampian Health Board

    Aberdeen, United Kingdom

    Recruiting now
    • Courtney Willis(contact)
  • Birmingham Women's and Childrens NHS Foundation Trust

    Birmingham, United Kingdom

    Recruiting now
    • Suzanne Gatz(contact)
  • The Royal Orthopaedic Hospital NHS Foundation Trust

    Birmingham, United Kingdom

    Recruiting now
    • Michael Parry(contact)
  • University Hospitals Birmingham NHS Foundation Trust

    Birmingham, United Kingdom

    Recruiting now
    • Jenny Sherriff(contact)
  • Cambridge University Hospitals NHS Foundation Trust

    Cambridge, United Kingdom

    Recruiting now
    • Han Wong(contact)
  • Cardiff and Vale University LHB

    Cardiff, United Kingdom

    Recruiting now
    • Cathy Morley-Jacob(contact)
  • NHS Lothian Health Board

    Edinburgh, United Kingdom

    Recruiting now
    • Angela Jesudason(contact)
  • NHS Greater Glasgow and Clyde Health Board

    Glasgow, United Kingdom

    Recruiting now
    • Ioanna Nixon(contact)
    • Diana McIntosh(contact)
  • Leeds Teaching Hospitals NHS Trust

    Leeds, United Kingdom

    Recruiting now
    • Dan Stark(contact)
    • Simone Wilkins(contact)
  • University Hospitals of Leicester NHS Trust

    Leicester, United Kingdom

    Recruiting now
    • Sunita Dhir(contact)
  • Alder Hey Children's NHS Foundation Trust

    Liverpool, United Kingdom

    Recruiting now
    • Colin Thorbinson(contact)
  • The Clatterbridge Cancer Centre NHS Foundation Trust

    Liverpool, United Kingdom

    Recruiting now
    • Nasim Ali(contact)
  • Manchester University NHS Foundation Trust

    Manchester, United Kingdom

    Recruiting now
    • Bernadette Brennan(contact)
  • The Christie NHS Foundation Trust

    Manchester, United Kingdom

    Recruiting now
    • Martin McCabe(contact)
  • The Newcastle upon Tyne Hospitals NHS Foundation Trust

    Newcastle, United Kingdom

    Recruiting now
    • Kenneth Rankin(contact)
  • Nottingham University Hospitals NHS Trust

    Nottingham, United Kingdom

    Recruiting now
    • Ivo Hennig(contact)
  • The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust

    Oswestry, United Kingdom

    Recruiting now
    • Paul Cool(contact)
  • Oxford University Hospitals NHS Foundation Trust

    Oxford, United Kingdom

    Recruiting now
    • Sarah Pratap(contact)
  • Sheffield Children's NHS Foundation Trust

    Sheffield, United Kingdom

    Recruiting now
    • Daniel Yeomanson(contact)
  • Sheffield Teaching Hospitals NHS Foundation Trust

    Sheffield, United Kingdom

    Recruiting now
    • Robin Young(contact)
  • University Hospital Southampton NHS Foundation Trust

    Southampton, United Kingdom

    Recruiting now
    • Peter Simmonds(contact)
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* New histological diagnosis of osteosarcoma or in the absence of osteoid seen on biopsy, pathology and imaging supportive of a diagnosis of osteosarcoma. (It is well recognised that some patients may present with features suggestive of osteosarcoma (under 40 years, radiological abnormality compatible) but in whom no osteoid is detected in needle biopsy. Although categorised as spindle cell tumour of bone, such patients are usually treated in an identical approach to osteosarcoma. A definite diagnosis of osteosarcoma is then often possible after surgery when the entire resection specimen is available.)
* Written informed consent of patient and/or parent/legal guardian.

Exclusion Criteria:

• Diagnosis more than four months prior to registration.

Updated 2024-08-02 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.